BBT Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,212
Closed -$296K 309
2018
Q4
$296K Buy
+2,212
New +$363K 0.27% 180
2016
Q2
Sell
-27,500
Closed -$7.37M 115
2016
Q1
$7.37M Buy
+27,500
New +$7.87M 1.45% 22
2015
Q4
Sell
-50,300
Closed -$13.7M 162
2015
Q3
$13.7M Buy
50,300
+15,300
+44% +$4.7M 1.27% 25
2015
Q2
$10.6M Buy
+35,000
New +$10.4M 0.97% 35

Other funds holding AGN

BBT Capital Management's AGN Position: Q1 2019 in Review

BBT Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,212 shares — an estimated $296K sold.

BBT Capital Management first reported a position in AGN in Q2 2015 and held it in 4 quarters. The position peaked at $13.7M in Q3 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • BBT Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • BBT Capital Management sold 2,212 Allergan plc shares in Q1 2019, an estimated $296K.
  • BBT Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 4 quarters.
  • BBT Capital Management's Allergan plc position peaked at $13.7M in Q3 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on BBT Capital Management's 13F filing for Q1 2019, filed 10 May 2019.